1
|
Fan FF, Xu Q, Sun Q, Zhao SJ, Wang P and
Guo XR: Assessment of the reporting quality of randomized
controlled trials on treatment of coronary heart disease with
traditional Chinese medicine from the Chinese journal of integrated
traditional and Western medicine: A systematic review. PLoS One.
9:e863602014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Doyle F, Rohde D, Rutkowska A, Morgan K,
Cousins G and McGee H: Systematic review and meta-analysis of the
impact of depression on subsequent smoking cessation in patients
with coronary heart disease: 1990 to 2013. Psychosom Med. 76:44–57.
2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Tully PJ and Baumeister H: Collaborative
care for the treatment of comorbid depression and coronary heart
disease: A systematic review and meta-analysis protocol. Syst Rev.
3:1272014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Schwingshackl L and Hoffmann G: Dietary
fatty acids in the secondary prevention of coronary heart disease:
A systematic review, meta-analysis and meta-regression. BMJ Open.
4:e0044872014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tully PJ, Cosh SM and Baumeister H: The
anxious heart in whose mind? A systematic review and
meta-regression of factors associated with anxiety disorder
diagnosis, treatment and morbidity risk in coronary heart disease.
J Psychosom Res. 77:439–448. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li SM, Xu H and Chen KJ: Integrative
medicine on coronary heart disease: Annual academic review 2013.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:1029–1034. 2014.(In
Chinese). PubMed/NCBI
|
7
|
Ray IB, Menezes AR, Malur P, Hiltbold AE,
Reilly JP and Lavie CJ: Meditation and coronary heart disease: A
review of the current clinical evidence. Ochsner J. 14:696–703.
2014.PubMed/NCBI
|
8
|
Niermann C, Gorressen S, Klier M, Gowert
NS, Billuart P, Kelm M, Merx MW and Elvers M: Oligophrenin1
protects mice against myocardial ischemia and reperfusion injury by
modulating inflammation and myocardial apoptosis. Cell Signal.
28:967–978. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Guo CX, Jiang X, Zeng XJ, Wang HX, Li HH,
Du FH and Chen BX: Soluble receptor for advanced glycation
end-products protects against ischemia/reperfusion-induced
myocardial apoptosis via regulating the ubiquitin proteasome
system. Free Radic Biol Med. 94:17–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shi ZY, Liu Y, Dong L, Zhang B, Zhao M,
Liu WX, Zhang X and Yin XH: Cortistatin improves cardiac function
after acute myocardial infarction in rats by suppressing myocardial
apoptosis and endoplasmic reticulum stress. J Cardiovasc Pharmacol
Ther. 22:83–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nishikido T, Oyama J, Shiraki A, Komoda H
and Node K: Deletion of Apoptosis Inhibitor of Macrophage
(AIM)/CD5L attenuates the inflammatory response and infarct size in
acute myocardial infarction. J Am Heart Assoc. 5:e0028632016.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Kvan E, Pettersen KI, Landmark K and
Reikvam A: Treatment with statins after acute myocardial infarction
in patients >or=80 years: Underuse despite general acceptance of
drug therapy for secondary prevention. Pharmacoepidemiol Drug Saf.
15:261–267. 2006. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou Z, Rahme E, Abrahamowicz M, Tu JV,
Eisenberg MJ, Humphries K, Austin PC and Pilote L: Effectiveness of
statins for secondary prevention in elderly patients after acute
myocardial infarction: An evaluation of class effect. CMAJ.
172:1187–1194. 2005. View Article : Google Scholar : PubMed/NCBI
|
14
|
Iwakura K, Ito H, Kawano S, Okamura A,
Kurotobi T, Date M, Inoue K and Fujii K: Chronic pre-treatment of
statins is associated with the reduction of the no-reflow
phenomenon in the patients with reperfused acute myocardial
infarction. Eur Heart J. 27:534–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Matetzky S, Fefer P, Shenkman B, Shechter
M, Novikov I, Savion N, Varon D and Hod H: Statins have an early
antiplatelet effect in patients with acute myocardial infarction.
Platelets. 22:103–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lewinter C, Bland JM, Crouch S, Cleland
JG, Doherty P, LeWinter MM, Køber L, Hall AS and Gale CP: Impact of
aspirin and statins on long-term survival in patients hospitalized
with acute myocardial infarction complicated by heart failure: An
analysis of 1706 patients. Eur J Heart Fail. 16:95–102. 2014.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Verrier RL: Statins protect against
arrhythmogenic calcium alternans in the post-myocardial infarction
diabetic heart: Pleiotropy on steroids. Heart Rhythm. 14:1417–1418.
2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yamac AH and Kilic U: Effect of statins on
sirtuin 1 and endothelial nitric oxide synthase expression in young
patients with a history of premature myocardial infarction. Turk
Kardiyol Dern Ars. 46:205–215. 2018.PubMed/NCBI
|
19
|
Xu H, Yang YJ, Qian HY, Tang YD, Wang H
and Zhang Q: Rosuvastatin treatment activates JAK-STAT pathway and
increases efficacy of allogeneic mesenchymal stem cell
transplantation in infarcted hearts. Circ J. 75:1476–1485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Rajtik T, Carnicka S, Szobi A, Mesárošová
L, Máťuš M, Švec P, Ravingerová T and Adameová A: Pleiotropic
effects of simvastatin are associated with mitigation of apoptotic
component of cell death upon lethal myocardial reperfusion-induced
injury. Physiol Res. 61 (Suppl 2):S33–S41. 2012.PubMed/NCBI
|
21
|
Qiu R, Cai A, Dong Y, Zhou Y, Yu D, Huang
Y, Zheng D, Rao S, Feng Y and Mai W: SDF-1α upregulation by
atorvastatin in rats with acute myocardial infarction via nitric
oxide production confers anti-inflammatory and anti-apoptotic
effects. J Biomed Sci. 19:992012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Han L, Zhang X and Qian Y: Propofol
protects human cardiac AC16 cells from CoCl2-induced hypoxic
injury. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 44:307–314. 2019.(In
Chinese). PubMed/NCBI
|
23
|
Radecke CE, Warrick AE, Singh GD, Rogers
JH, Simon SI and Armstrong EJ: Coronary artery endothelial cells
and microparticles increase expression of VCAM-1 in myocardial
infarction. Thromb Haemost. 113:605–616. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Xiao S, Wang J and Xiao N: MicroRNAs as
noninvasive biomarkers in bladder cancer detection: A diagnostic
meta-analysis based on qRT-PCR data. Int J Biol Markers.
31:e276–e285. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Naganuma Y, Ichii O, Otsuka S, Hashimoto Y
and Kon Y: Analysis of TdT-mediated dUTP nick end labeling
(TUNEL)-positive cells associated with cardiac myogenesis in mouse
embryo. J Vet Med Sci. 75:283–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang R, Kang X, Wang Y, Wang F, Yu P,
Shen J and Fu L: Effects of carvedilol on ventricular remodeling
and the expression of β3-adrenergic receptor in a diabetic rat
model subjected myocardial infarction. Int J Cardiol. 222:178–184.
2016. View Article : Google Scholar : PubMed/NCBI
|
28
|
Bagno LL, Carvalho D, Mesquita F, Louzada
RA, Andrade B, Kasai-Brunswick TH, Lago VM, Suhet G, Cipitelli D,
Werneck-de-Castro JP and Campos-de-Carvalho AC: Sustained IGF-1
secretion by adipose-derived stem cells improves infarcted heart
function. Cell Transplant. 25:1609–1622. 2016. View Article : Google Scholar : PubMed/NCBI
|
29
|
Paradiso A, Caretto S, Leone A, Bove A,
Nisi R and De Gara L: ROS production and scavenging under anoxia
and re-oxygenation in arabidopsis cells: A balance between redox
signaling and impairment. Front Plant Sci. 7:18032016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Dirani M, Nasreddine W, Abdulla F and
Beydoun A: Seizure control and improvement of neurological
dysfunction in Lafora disease with perampanel. Epilepsy Behav Case
Rep. 2:164–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Hashemian M, Poustchi H,
Mohammadi-Nasrabadi F and Hekmatdoost A: Systematic review of zinc
biochemical indicators and risk of coronary heart disease. ARYA
Atheroscler. 11:357–365. 2015.PubMed/NCBI
|
32
|
Liu LL, Lin LR, Lu CX, Fu JG, Chao PL, Jin
HW, Zhang ZY and Yang TC: Expression of inflammatory and apoptosis
factors following coronary stent implantation in coronary heart
disease patients. Int Immunopharmacol. 11:1850–1854. 2011.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Chopra V, Wesorick DH, Sussman JB, Greene
T, Rogers M, Froehlich JB, Eagle KA and Saint S: Effect of
perioperative statins on death, myocardial infarction, atrial
fibrillation, and length of stay: A systematic review and
meta-analysis. Arch Surg. 147:181–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Gultekin N, Bulut G, Kucukates E, Yildiz
A, Kocas C and Bulut L: Apoptosis kinetics at reperfusion period in
patients with acute ST-Segment Elevation Myocardial Infarction
undergoing primary percutaneous coronary intervention and treated
with thrombolytic therapy. J Pak Med Assoc. 66:808–814.
2016.PubMed/NCBI
|
35
|
Pourafkari L, Visnjevac O, Ghaffari S and
Nader ND: Statin drugs mitigate cellular inflammatory response
after ST elevation myocardial infarction, but do not affect
in-hospital mortality. J Cardiovasc Thorac Res. 8:34–39. 2016.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Hochhauser E, Cheporko Y, Yasovich N,
Pinchas L, Offen D, Barhum Y, Pannet H, Tobar A, Vidne BA and Birk
E: Bax deficiency reduces infarct size and improves long-term
function after myocardial infarction. Cell Biochem Biophys.
47:11–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
37
|
Li T, Kilic A, Wei X, Wu C, Schwartzbauer
G, Yankey GK, DeFilippi C, Bond M, Wu ZJ and Griffith BP: Regional
imbalanced activation of the calcineurin/BAD apoptotic pathway and
the PI3K/Akt survival pathway after myocardial infarction. Int J
Cardiol. 166:158–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
38
|
Lv FH, Yin HL, He YQ, Wu HM, Kong J, Chai
XY and Zhang SR: Effects of curcumin on the apoptosis of
cardiomyocytes and the expression of NF-κB, PPAR-γ and Bcl-2 in
rats with myocardial infarction injury. Exp Ther Med. 12:3877–3884.
2016. View Article : Google Scholar : PubMed/NCBI
|
39
|
Mercier E, Cochery-Nouvellon E, Lavigne G,
Bertinchant JP and Gris JC: In support of the revised World Health
Organization diagnostic criteria for essential thrombocythemia:
JAK2 V617F and premature myocardial infarction. J Thromb Haemost.
6:206–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
40
|
Enomoto D, Obana M, Miyawaki A, Maeda M,
Nakayama H and Fujio Y: Cardiac-specific ablation of the STAT3 gene
in the subacute phase of myocardial infarction exacerbated cardiac
remodeling. Am J Physiol Heart Circ Physiol. 309:H471–H480. 2015.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Wu J, Yu J, Xie P, Maimaitili Y, Wang J,
Yang L, Ma H, Zhang X, Yang Y and Zheng H: Sevoflurane
postconditioning protects the myocardium against
ischemia/reperfusion injury via activation of the JAK2-STAT3
pathway. PeerJ. 5:e31962017. View Article : Google Scholar : PubMed/NCBI
|
42
|
Luo R, Chen X, Ma H, Yao C, Liu M, Tao J
and Li X: Myocardial caspase-3 and NF-κB activation promotes
calpain-induced septic apoptosis: The role of Akt/eNOS/NO pathway.
Life Sci. 222:195–202. 2019. View Article : Google Scholar : PubMed/NCBI
|
43
|
Zhao Q, Cui Z, Zheng Y, Li Q, Xu C, Sheng
X, Tao M and Xu H: Fenofibrate protects against acute myocardial
I/R injury in rat by suppressing mitochondrial apoptosis as
decreasing cleaved caspase-9 activation. Cancer Biomark.
19:455–463. 2017. View Article : Google Scholar : PubMed/NCBI
|